Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 35.57
-1.69 %
$ 1.96 B
Market Cap
33.24
P/E
Price Target
Average
8.94%
Revenue Forecast
Estimate
8.52%
EBIT
Estimate
146.57%
Net Income
Estimate
261.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Supernus Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for SUPN of $38.8 , with forecasts ranging from a low of $36 to a high of $41 .
SUPN Lowest Price Target
Wall Street Target
36 USD
1.21%
SUPN Average Price Target
Wall Street Target
38.8 USD
8.94%
SUPN Highest Price Target
Wall Street Target
41 USD
15.27%
REVENUE FORECAST
Revenue Forecast Chart SUPN
EBIT FORECAST
EBIT Forecast Chart SUPN
NET INCOME FORECAST
Net Income Chart SUPN